Scarica l'app Stockscreener
3.04
1.67%
0.05
Dopo l'orario di chiusura:
3.04
Precedente Chiudi:
$2.99
Aprire:
$2.97
Volume 24 ore:
222.17K
Relative Volume:
0.44
Capitalizzazione di mercato:
$403.03M
Reddito:
$433.14M
Utile/perdita netta:
$4.95M
Rapporto P/E:
37.25
EPS:
0.0816
Flusso di cassa netto:
$6.55M
1 W Prestazione:
+2.01%
1M Prestazione:
-1.30%
6M Prestazione:
+22.09%
1 anno Prestazione:
+28.27%
Intervallo 1D:
$2.96
$3.09
Intervallo di 1 settimana:
$2.75
$3.09
Portata 52W:
$1.96
$4.705
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Nome
Organogenesis Holdings Inc
Settore
Telefono
781-575-0775
Indirizzo
85 DAN ROAD, CANTON, MA
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-11-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-08-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-01-10 | Iniziato | SVB Leerink | Outperform |
| 2019-08-26 | Ripresa | Credit Suisse | Outperform |
| 2019-05-02 | Iniziato | Credit Suisse | Outperform |
| 2019-04-17 | Iniziato | Oppenheimer | Outperform |
| 2019-04-11 | Iniziato | SunTrust | Buy |
Mostra tutto
Organogenesis Holdings Inc Borsa (ORGO) Ultime notizie
Organogenesis (ORGO) Set to Announce Quarterly Earnings on Tuesday - MarketBeat
Organogenesis Holdings And 2 Other US Penny Stocks To Watch - Simply Wall St
Mass. company offered millions to manufacture artificial skin in the Ocean StateProvidence Business First - The Business Journals
Business | McKee Administration Poised to Give Major Incentives to Boston Biotech Firm - GoLocalProv
Organogenesis eyes former Rubius site in SmithfieldProvidence Business First - The Business Journals
Mass.-based biotech firm looks to expand to former Rubius facility in Smithfield - Providence Business News
Shareholders in Organogenesis Holdings (NASDAQ:ORGO) are in the red if they invested three years ago - Yahoo Finance
Assenagon Asset Management S.A. Has $5.48 Million Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024 - The Manila Times
Market Highlights: Organogenesis Holdings Inc (ORGO) Ends on a High Note at 3.09 - The Dwinnex
Cubist Systematic Strategies LLC Acquires 88,175 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis: Lurking Disruption With Recovery To Follow (NASDAQ:ORGO) - Seeking Alpha
Cantor Fitzgerald Comments on Organogenesis Holdings Inc.'s FY2024 Earnings (NASDAQ:ORGO) - MarketBeat
Amniotic Membrane Market to See Booming Growth 2024-2031 | Smith - openPR
Dimensional Fund Advisors LP Raises Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Purchased by AQR Capital Management LLC - Defense World
AQR Capital Management LLC Grows Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers - ForexTV.com
Healthy Upside Potential: Organogenesis Holdings Inc (ORGO) - SETE News
Organogenesis Holdings Inc. (NASDAQ:ORGO) Short Interest Update - MarketBeat
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Acquired by Massachusetts Financial Services Co. MA - Defense World
Bank of New York Mellon Corp Increases Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
WINTON GROUP Ltd Sells 4,139 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Are Organogenesis Holdings Inc’shares a good deal? - US Post News
Wealth Dimensions Group Ltd. Grows Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Acadian Asset Management LLC Increases Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Why Investors Shouldn't Be Surprised By Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Low P/S - Simply Wall St
Wound Care Biologics Market Business Strategies, Share, Growth - openPR
Ratio Revelations: Organogenesis Holdings Inc (ORGO)’s Financial Metrics in the Spotlight - The Dwinnex
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September - ForexTV.com
Organogenesis Holdings Inc’s results are impressive - US Post News
Comprehensive Study of Asia Pacific Wound Care Biologics Market - openPR
There is no doubt that Organogenesis Holdings Inc (ORGO) ticks all the boxes. - SETE News
Examining Organogenesis Holdings Inc (ORGO) stock is warranted - US Post News
Financial Analysis: Organogenesis Holdings Inc (ORGO)’s Ratios Unveil Key Insights - The Dwinnex
Organogenesis Holdings Inc (ORGO) expanding its growth trajectory ahead - SETE News
Assenagon Asset Management S.A. Purchases 3,005,450 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Vanguard Group Inc. Sells 1,825,428 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Organogenesis Holdings Inc (ORGO) presents a great opportunity, but the stock is slightly overvalued - US Post News
Company’s Banking Shares: Up -43.46% from 52-Week Low, But Can the Momentum Hold? - The InvestChronicle
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Organogenesis Holdings Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class ActionORGO - Marketscreener.com
Market Highlights: Organogenesis Holdings Inc (ORGO) Ends on a Low Note at 2.42 - The Dwinnex
Organogenesis Holdings Second Quarter 2024 Earnings: US$0.13 loss per share (vs US$0.04 profit in 2Q 2023) - Simply Wall St
Organogenesis Holdings Inc (ORGO) can make a big difference with a little luck - SETE News
Organogenesis Holdings Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Organogenesis exceeds Q2 revenue expectation at $130.2 million - Investing.com
Organogenesis Holdings Inc. Reports Second Quarter 2024 Financial Results - ForexTV.com
Microsoft Corp (MSFT-Q) QuotePress Release - The Globe and Mail
Meta Platforms Inc (META-Q) QuotePress Release - The Globe and Mail
Organogenesis (ORGO) Q2 2024 Earnings Call Transcript - The Motley Fool
Organogenesis Holdings Inc Azioni (ORGO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Organogenesis Holdings Inc Azioni (ORGO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| ERANI ALBERT | 10% Owner |
Jan 09 '24 |
Sale |
4.37 |
197,921 |
863,985 |
59,025,106 |
| ERANI ALBERT | 10% Owner |
Jan 10 '24 |
Sale |
4.28 |
17,972 |
76,875 |
59,007,134 |
| ERANI ALBERT | 10% Owner |
Jan 09 '24 |
Sale |
4.37 |
197,921 |
863,985 |
59,025,106 |
| ERANI ALBERT | 10% Owner |
Jan 10 '24 |
Sale |
4.28 |
17,972 |
76,875 |
59,007,134 |
0.88%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):